MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)

Q: What does CUSIP 61559X104 represent in this 13F holders report?

CUSIP 61559X104 is the security identifier for MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share in Q2 2026?

19 institutional investors reported MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 61559X104

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Class A ordinary share, par value $0.0001 per share
Total 13F shares: 1,057,545
Total 13F value: $20,585,630
Share change: +352,249
Put/Call ratio: 41%
SEC-reported price per share: $19.47
Number of holders: 19
Value change: +$6,903,051
Number of buys: 14
Number of sells: 6
Shares outstanding: 81,224,792

Security key

61559X104

Report period

Q2 2026

Institutions

Top holders

MLTX full security history Ownership snapshot Full 13F holder table MoonLake Immunotherapeutics SEC filings MoonLake Immunotherapeutics company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BIOTECHNOLOGY VALUE FUND L P

Disclosed value leader

BIOTECHNOLOGY VALUE FUND L P

Comparable rows

15/15

Latest evidence

25 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 20% 13D/G row: BIOTECHNOLOGY VALUE FUND L P Showing 1-6 of 15 holder rows.

Quick read

BIOTECHNOLOGY VALUE FUND L P leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BIOTECHNOLOGY VALUE FUND L P's linked filing trail.

Comparable ownership Top 5

BIOTECHNOLOGY VALUE FUND L P 20%

Deep Track Capital, LP 6.5%

Cormorant Asset Management, LP 6.2%

PRICE T ROWE ASSOCIATES INC /MD/ 4.7%

Avoro Capital Advisors LLC 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BIOTECHNOLOGY VALUE FUND L P	13D/G 3/4/5 BVF PARTNERS L P/IL · Director, 10%+ Owner 13D/G 3/4/5	20%	$298,903,985 16,001,284 shares	$0	25 Jun 2026
Deep Track Capital, LP	13F 13D/G Company 13F 13D/G	6.5% from 13D/G	$119,461,206 6,408,863 shares	—	31 Mar 2026
Cormorant Asset Management, LP	13D/G 13F Company 13D/G 13F	6.2%	$83,515,271 4,480,433 shares	+$2,330,000	31 Mar 2026
PRICE T ROWE ASSOCIATES INC /MD/	13D/G 13F T. Rowe Price Associates, Inc. · Company 13D/G 13F	4.7%	$117,334,991 2,974,271 shares	-$14,571,725	31 Mar 2025
Avoro Capital Advisors LLC	13D/G 13D/G	3.2%	$14,340,000 2,000,000 shares	-$15,415,500	30 Sep 2025
Bihua Chen	13D/G 3/4/5 Chen Bihua · Former 10% Owner 13D/G 3/4/5	3.1%	$108,084,177 1,994,173 shares	$0	30 Sep 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,057,545

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

147

Q2 2026 holders

Holder diff

-128

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %